NASDAQ:CME - CME Group Stock Price, Price Target & More

$164.94 -0.26 (-0.16 %)

(As of 04/19/2018 11:18 AM ET)

Previous Close$165.20

Today's Range$164.80 - $165.98

52-Week Range$114.82 - $171.71

Volume302,523 shs

Average Volume1.73 million shs

Market Capitalization$56.08 billion

P/E Ratio34.66

Dividend Yield1.70%

Beta0.56

About CME Group (NASDAQ:CME)

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions, as well as provides hosting, connectivity, and customer support for electronic trading through its co-location services. It also provides clearing and settlement services for exchange-traded contracts, as well as for cleared swaps; and regulatory reporting solutions for market participants through its repository services in the United States, the United Kingdom, Canada, and Australia. In addition, the company offers a range of market data services, including live quotes, delayed quotes, market reports, and historical data services, as well as index services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Security & commodity brokers, dealers, exchanges & services

Sub-IndustrySpecialized Finance

SectorFinance

SymbolNASDAQ:CME

CUSIP12572Q10

Webwww.cmegroup.com

Phone312-930-1000

Debt

Debt-to-Equity Ratio0.10%

Current Ratio1.03%

Quick Ratio1.03%

Price-To-Earnings

Trailing P/E Ratio34.66

Forward P/E Ratio24.04

P/E Growth2.29

Sales & Book Value

Annual Sales$3.64 billion

Price / Sales15.40

Cash Flow$5.4061 per share

Price / Cash30.51

Book Value$66.07 per share

Price / Book2.50

Profitability

EPS (Most Recent Fiscal Year)$4.77

Net Income$4.06 billion

Net Margins111.49%

Return on Equity7.68%

Return on Assets2.11%

Miscellaneous

Employees2,830

Outstanding Shares340,390,000

How to Become a New Pot Stock Millionaire

CME Group (NASDAQ:CME) Frequently Asked Questions

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group announced a quarterly dividend on Wednesday, February 7th. Stockholders of record on Friday, March 9th will be paid a dividend of $0.70 per share on Monday, March 26th. This represents a $2.80 annualized dividend and a dividend yield of 1.70%. The ex-dividend date of this dividend is Thursday, March 8th. This is a boost from CME Group's previous quarterly dividend of $0.66. View CME Group's Dividend History.

How were CME Group's earnings last quarter?

CME Group (NASDAQ:CME) posted its earnings results on Thursday, February, 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.10 by $0.02. The financial services provider had revenue of $900 million for the quarter, compared to analysts' expectations of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business's quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.14 earnings per share. View CME Group's Earnings History.

When is CME Group's next earnings date?

CME Group is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for CME Group.

What price target have analysts set for CME?

13 Wall Street analysts have issued 1 year target prices for CME Group's stock. Their predictions range from $133.00 to $197.00. On average, they expect CME Group's stock price to reach $164.4615 in the next year. View Analyst Ratings for CME Group.

Who are some of CME Group's key competitors?

Some companies that are related to CME Group include Royal Bank of Canada (RY), Santander Group (SAN), Allianz (AZSEY), Toronto–Dominion Bank (TD), Scotiabank (BNS), Ita� Unibanco (ITUB), Goldman Sachs (GS), BNP Paribas (BNPQY), Morgan Stanley (MS), Mitsubishi UFJ Financial Group (MTU), HDFC Bank (HDB), BlackRock (BLK), U.S. Bancorp (USB), Australia and New Zealand Banking Group (ANZ), American Express (AXP), National Australia Bank (NAB), China Life Insurance (LFC) and Westpac (WBK).

Who are CME Group's key executives?

CME Group's management team includes the folowing people:

Mr. Terrence A. Duffy, Chairman & CEO (Age 60)
Mr. Bryan Thomas Durkin, Pres (Age 57)
Mr. John W. Pietrowicz, Sr. MD & CFO (Age 53)
Mr. Sean P. Tully, Sr. MD and Global Head of Financial & OTC Products (Age 54)
Ms. Julie Holzrichter, Sr. MD & COO (Age 49)

Has CME Group been receiving favorable news coverage?

Media headlines about CME stock have been trending somewhat positive on Thursday, according to Accern Sentiment. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CME Group earned a news sentiment score of 0.22 on Accern's scale. They also gave news coverage about the financial services provider an impact score of 45.01 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $164.94.

How big of a company is CME Group?

CME Group has a market capitalization of $56.08 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]

MarketBeat Community Rating for CME Group (CME)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		443 (Vote Outperform)
Underperform Votes:		489 (Vote Underperform)
Total Votes:		932

MarketBeat's community ratings are surveys of what our community members think about CME Group and other stocks. Vote "Outperform" if you believe CME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CME will underperform the S&P 500 over the long term. You may vote once every thirty days.

CME Group (NASDAQ:CME) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

13 Wall Street analysts have issued ratings and price targets for CME Group in the last 12 months. Their average twelve-month price target is $164.4615, suggesting that the stock has a possible downside of 0.29%. The high price target for CME is $197.00 and the low price target for CME is $133.00. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.77	2.75	2.73	2.73
Ratings Breakdown:	0 Sell Rating(s) 3 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$164.4615	$157.25	$141.75	$138.8889
Price Target Upside:	0.29% downside	6.35% downside	3.95% upside	1.85% upside

CME Group (NASDAQ:CME) Consensus Price Target History

Price Target History for CME Group (NASDAQ:CME)

CME Group (NASDAQ:CME) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/9/2018	Sanford C. Bernstein	Initiated Coverage	Outperform -> Outperform	$190.00	High
4/6/2018	Deutsche Bank	Boost Price Target	Buy -> Buy	$185.00 -> $197.00	Low
3/8/2018	Bank of America	Boost Price Target	Buy -> Buy	$175.00 -> $185.00	Low
2/7/2018	Goldman Sachs	Upgrade	Neutral -> Buy	$180.00	Low
2/2/2018	Barclays	Boost Price Target	Overweight -> Overweight	$170.00 -> $175.00	Medium
2/2/2018	Sandler O'Neill	Reiterated Rating	Buy	$175.00	Low
1/29/2018	Citigroup	Reiterated Rating	Buy -> Buy	$155.00 -> $172.00	Low
1/25/2018	Berenberg Bank	Initiated Coverage	Hold -> Hold	$170.00	Low
10/16/2017	Royal Bank of Canada	Boost Price Target	Outperform -> Outperform	$135.00 -> $147.00	N/A
10/4/2017	Wells Fargo	Boost Price Target	Market Perform	$130.00 -> $145.00	Low
9/21/2017	Keefe, Bruyette & Woods	Reiterated Rating	Hold	$133.00	Low
9/6/2017	UBS	Reiterated Rating	Buy	$134.00 -> $135.00	Low
7/17/2017	Jefferies Group	Reiterated Rating	Buy	$128.00 -> $134.00	Low
6/12/2017	AltaCorp Capital	Downgrade	Outperform -> Speculative		N/A
3/13/2017	Clarus Securities	Reiterated Rating	Buy		N/A
1/31/2017	JPMorgan Chase	Downgrade	Overweight -> Neutral		N/A
6/1/2016	Credit Suisse Group	Lower Price Target	Neutral	$100.00 -> $94.00	N/A
5/19/2016	Sterne Agee CRT	Initiated Coverage	Neutral	$90.00	N/A
5/3/2016	Buckingham Research	Initiated Coverage	Buy	$105.00	N/A

(Data available from 4/19/2016 forward)

CME Group (NASDAQ:CME) Earnings History and Estimates Chart

Earnings by Quarter for CME Group (NASDAQ:CME)

CME Group (NASDAQ:CME) Earnings Estimates

2018 EPS Consensus Estimate: $6.65

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$1.84	$1.84	$1.84
Q2 2018	1	$1.64	$1.64	$1.64
Q3 2018	1	$1.60	$1.60	$1.60
Q4 2018	1	$1.57	$1.57	$1.57

CME Group (NASDAQ CME) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/26/2018		$1.54					N/A
2/1/2018	Q4 2017	$1.10	$1.12	$886.85 million	$900.00 million	View	Listen
10/26/2017	Q3 2017	$1.16	$1.19	$890.22 million	$890.80 million	View	N/A
8/1/2017	Q2 2017	$1.20	$1.23	$931.05 million	$925.00 million	View	Listen
4/27/2017	Q1 2017	$1.20	$1.22	$932.06 million	$929.00 million	View	N/A
2/2/2017	Q416	$1.11	$1.14	$881.46 million	$913.00 million	View	Listen
10/27/2016	Q316	$1.04	$1.05	$855.94 million	$842.00 million	View	Listen
7/28/2016	Q216	$1.11	$1.14	$897.84 million	$906.00 million	View	Listen
4/28/2016	Q116	$1.15	$1.15	$947.15 million	$934.00 million	View	Listen
2/5/2016	Q415	$0.90	$0.92	$810.77 million	$814.00 million	View	N/A
10/29/2015	Q315	$0.98	$1.02	$841.06 million	$850.00 million	View	Listen
7/30/2015	Q215	$0.92	$0.95	$783.74 million	$820.00 million	View	Listen
4/30/2015	Q115	$0.95	$0.98	$838.12 million	$842.70 million	View	N/A
2/5/2015	Q414	$0.93	$0.95	$800.60 million	$841.10 million	View	N/A
10/30/2014	Q314	$0.82	$0.84	$747.58 million	$762.00 million	View	N/A
7/31/2014	Q214	$0.80	$0.77	$740.64 million	$731.60 million	View	N/A
5/1/2014	Q114	$0.83	$0.83	$368.13 million	$777.00 million	View	N/A
2/4/2014	Q413	$0.68	$0.64	$691.29 million	$687.00 million	View	Listen
11/4/2013	Q313	$0.75	$0.75	$723.43 million	$715.00 million	View	N/A
8/1/2013	Q2 2013	$0.87	$0.93	$798.58 million	$816.00 million	View	N/A
5/2/2013	Q1 2013	$0.73	$0.71	$711.88 million	$719.00 million	View	N/A
2/5/2013	Q4 2012	$0.64	$0.63	$664.16 million	$661.00 million	View	N/A
10/25/2012		$0.70	$0.70			View	N/A
7/26/2012		$0.83	$0.74			View	N/A
4/26/2012		$4.03	$4.02			View	N/A
2/2/2012		$3.72	$3.55			View	N/A
11/1/2011		$4.67	$4.74			View	N/A
7/28/2011		$4.20	$4.38			View	N/A
4/28/2011		$4.20	$4.36			View	N/A
2/3/2011		$3.82	$3.77			View	N/A
10/28/2010	Q3 2010	$0.73	$0.73			View	N/A
7/29/2010	Q2 2010	$0.86	$0.88			View	N/A
4/29/2010	Q1 2010	$0.72	$0.72			View	N/A
2/4/2010	Q4 2009	$0.69	$0.67			View	N/A
10/29/2009	Q3 2009	$0.66	$0.67			View	N/A
7/23/2009	Q2 2009	$0.65	$0.67			View	N/A
4/23/2009	Q1 2009	$0.65	$0.64			View	N/A
2/3/2009	Q4 2008	$0.70	$0.72			View	N/A
10/29/2008	Q3 2008	$0.81	$0.83			View	N/A
7/22/2008	Q2 2008	$0.79	$0.79			View	N/A
4/22/2008	Q1 2008	$0.95	$1.08			View	N/A
2/5/2008	Q4 2007	$0.73	$0.75			View	N/A

(Earnings results data provided by Zacks Investment Research)

CME Group (NASDAQ:CME) Dividend Information

CME Group pays an annual dividend of $2.80 per share, with a dividend yield of 1.70%. CME's most recent quarterly dividend payment was Monday, March 26. CME Group pays out 58.70% of its earnings out as a dividend.

Most Recent Dividend:	3/26/2018
Annual Dividend:	$2.80
Dividend Yield:	1.70%
Payout Ratio:	58.70% (Trailing 12 Months of Earnings) 40.82% (Based on This Year's Estimates) 39.94% (Based on Next Year's Estimates)

Dividend Payments by Quarter for CME Group (NASDAQ:CME)

CME Group (NASDAQ:CME) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/7/2018	quarterly	$0.70	1.73%	3/8/2018	3/9/2018	3/26/2018
12/6/2017		$3.50		12/27/2017	12/28/2017	1/16/2018
12/6/2017	None	$3.50		12/27/2017	12/28/2017	1/15/2018
11/8/2017	quarterly	$0.66	1.91%	12/7/2017	12/8/2017	12/27/2017
8/2/2017	quarterly	$0.66	2.11%	9/7/2017	9/8/2017	9/25/2017
5/23/2017	quarterly	$0.66	2.24%	6/7/2017	6/9/2017	6/26/2017
2/8/2017	quarterly	$0.66	2.23%	3/8/2017	3/10/2017	3/27/2017
12/7/2016		$3.25		12/23/2016	12/28/2016	1/13/2017
11/9/2016	quarterly	$0.60	2.05%	12/7/2016	12/9/2016	12/28/2016
8/3/2016	quarterly	$0.60	2.3%	9/7/2016	9/9/2016	9/26/2016
5/17/2016	quarterly	$0.60	2.51%	6/8/2016	6/10/2016	6/27/2016
2/3/2016	quarterly	$0.60	2.71%	3/8/2016	3/10/2016	3/28/2016
12/9/2015		$2.90		12/23/2015	12/28/2015	1/12/2016
11/11/2015	quarterly	$0.50	2.1%	12/8/2015	12/10/2015	12/28/2015
8/5/2015	quarterly	$0.50	2.06%	9/8/2015	9/10/2015	9/25/2015
5/19/2015	quarterly	$0.50	2.13%	6/8/2015	6/10/2015	6/25/2015
2/4/2015	quarterly	$0.50	2.2%	3/6/2015	3/10/2015	3/25/2015
12/11/2014	special	$2.00	2.12%	12/24/2014	12/29/2014	1/13/2015
11/5/2014	quarterly	$0.47	2.18%	12/8/2014	12/10/2014	12/26/2014
8/6/2014	quarterly	$0.47	2.57%	9/8/2014	9/10/2014	9/25/2014
5/20/2014	quarterly	$0.47	2.68%	6/6/2014	6/10/2014	6/25/2014
2/5/2014	quarterly	$0.47	2.48%	3/6/2014	3/10/2014	3/25/2014
12/13/2013	special	$2.60	2.21%	12/24/2013	12/27/2013	1/14/2014
11/5/2013	quarterly	$0.45	2.41%	12/6/2013	12/10/2013	12/26/2013
8/7/2013	quarterly	$0.45	2.49%	9/6/2013	9/10/2013	9/25/2013
5/23/2013	quarterly	$0.45	2.79%	6/6/2013	6/10/2013	6/25/2013
1/30/2013	quarterly	$0.45	3.11%	3/6/2013	3/8/2013	3/25/2013

(Data available from 1/1/2013 forward)

CME Group (NASDAQ CME) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.57%
Institutional Ownership Percentage: 83.41%

Insider Trading History for CME Group (NASDAQ:CME)

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

CME Group (NASDAQ CME) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/10/2018	John W Pietrowicz	CFO	Sell	2,500	$161.02	$402,550.00	34,957
2/20/2018	Hilda Harris Piell	Insider	Sell	3,299	$163.52	$539,452.48
2/14/2018	Ronald A Pankau	Director	Sell	200	$159.91	$31,982.00	3,809
2/6/2018	Terrence A Duffy	Chairman	Sell	20,000	$151.66	$3,033,200.00	99,239
2/5/2018	Leo Melamed	Director	Sell	7,300	$155.78	$1,137,194.00	10,537
2/2/2018	Derek Sammann	Insider	Sell	2,400	$161.66	$387,984.00	40,153
1/9/2018	John W Pietrowicz	CFO	Sell	7,500	$151.50	$1,136,250.00	32,376
12/18/2017	Jack J Tobin	Insider	Sell	2,325	$152.28	$354,051.00	17,574
12/7/2017	Julie Winkler	Insider	Sell	2,457	$150.41	$369,557.37	16,318
11/30/2017	Jeffrey M Bernacchi	Director	Sell	1,501	$149.75	$224,774.75	60,194
11/30/2017	Kimberly S Taylor	Insider	Sell	8,125	$150.00	$1,218,750.00	120,590
11/28/2017	Julie Holzrichter	COO	Sell	12,920	$144.08	$1,861,513.60
11/17/2017	Sunil Cutinho	Insider	Sell	2,600	$139.57	$362,882.00	22,301
11/2/2017	John W Pietrowicz	CFO	Sell	5,175	$139.70	$722,947.50
10/11/2017	John W Pietrowicz	CFO	Sell	2,500	$136.83	$342,075.00
10/5/2017	Hilda Harris Piell	Insider	Sell	1,350	$138.00	$186,300.00
9/11/2017	Dennis Suskind	Director	Sell	750	$129.34	$97,005.00	5,059
9/6/2017	Hilda Harris Piell	Insider	Sell	714	$129.00	$92,106.00	28,844
8/28/2017	Daniel R Glickman	Director	Sell	850	$126.65	$107,652.50	13,799
8/9/2017	Martin J Gepsman	Director	Sell	200	$126.14	$25,228.00	43,311
8/8/2017	Bryan T Durkin	President	Sell	9,200	$125.13	$1,151,196.00	70,938
8/7/2017	Julie Holzrichter	COO	Sell	11,915	$125.67	$1,497,358.05	43,657
8/3/2017	Ronald A Pankau	Director	Sell	300	$124.78	$37,434.00	4,009
8/2/2017	Terrence A Duffy	Chairman	Sell	21,815	$123.89	$2,702,660.35	110,711
7/10/2017	John W Pietrowicz	CFO	Sell	2,500	$124.50	$311,250.00	38,495
6/14/2017	Kathleen M Cronin	Insider	Sell	8,125	$127.35	$1,034,718.75	38,174
6/13/2017	Kimberly S Taylor	Insider	Sell	7,400	$125.95	$932,030.00	115,330
6/13/2017	Timothy S Bitsberger	Director	Sell	800	$125.93	$100,744.00	9,024
6/12/2017	Julie Winkler	Insider	Sell	4,315	$124.95	$539,159.25	19,670
6/9/2017	Kevin Kometer	Insider	Sell	4,125	$122.44	$505,065.00	54,820
6/7/2017	Derek Sammann	Insider	Sell	2,100	$118.24	$248,304.00	36,595
6/7/2017	Julie Holzrichter	COO	Sell	5,925	$118.23	$700,512.75	42,082
6/5/2017	Derek Sammann	Insider	Sell	2,100	$117.86	$247,506.00	31,026
5/24/2017	Sunil Cutinho	Insider	Sell	10,265	$117.85	$1,209,730.25	21,690
4/28/2017	Dennis Suskind	Director	Sell	1,099	$115.29	$126,703.71	5,000
4/10/2017	John W Pietrowicz	CFO	Sell	2,500	$117.85	$294,625.00	40,995
3/14/2017	Hilda Harris Piell	Insider	Sell	3,043	$124.26	$378,123.18	26,082
2/24/2017	Julie Winkler	Insider	Sell	5,888	$122.53	$721,456.64	14,095
2/24/2017	Ronald A Pankau	Director	Sell	500	$122.11	$61,055.00	3,500
2/3/2017	Dennis Suskind	Director	Sell	1,000	$121.00	$121,000.00	6,099
1/9/2017	John W Pietrowicz	CFO	Sell	7,500	$116.77	$875,775.00	39,669
12/29/2016	Kimberly S Taylor	Insider	Sell	1,351	$115.88	$156,553.88	99,607
12/28/2016	Bryan T Durkin	President	Sell	14,886	$116.39	$1,732,581.54	65,960
12/12/2016	John W Pietrowicz	CFO	Sell	4,625	$123.30	$570,262.50	51,794
12/12/2016	Ronald A Pankau	Director	Sell	382	$123.53	$47,188.46	4,000
12/9/2016	Dennis Suskind	Director	Sell	1,000	$122.45	$122,450.00	7,099
12/8/2016	Terrence A Duffy	CEO	Sell	27,550	$120.44	$3,318,122.00	137,914
12/7/2016	Hilda Harris Piell	Insider	Sell	5,850	$120.00	$702,000.00	29,500
11/30/2016	Bryan T Durkin	President	Sell	15,000	$112.85	$1,692,750.00	68,680
11/30/2016	Kimberly S Taylor	Insider	Sell	2,300	$113.00	$259,900.00	100,958
11/25/2016	Terrence A Duffy	CEO	Sell	17,375	$112.58	$1,956,077.50	127,739
11/2/2016	Dennis Suskind	Director	Sell	2,000	$100.52	$201,040.00	8,499
10/31/2016	Bryan T Durkin	Insider	Sell	15,000	$100.00	$1,500,000.00	58,454
9/29/2016	Kimberly S Taylor	Insider	Sell	2,300	$106.01	$243,823.00	105,558
9/28/2016	Bryan T Durkin	Insider	Sell	14,990	$105.10	$1,575,449.00	66,936
9/19/2016	Hilda Harris Piell	Insider	Sell	893	$110.00	$98,230.00	29,125
9/19/2016	Phupinder Gill	CEO	Sell	30,002	$110.00	$3,300,220.00	116,222
9/13/2016	Jeffrey M Bernacchi	Director	Sell	5,187	$107.70	$558,639.90	60,886
9/6/2016	Bryan T Durkin	Insider	Sell	15,000	$107.75	$1,616,250.00	63,967
9/2/2016	Martin J Gepsman	Director	Sell	300	$109.00	$32,700.00	42,802
9/1/2016	Dennis Suskind	Director	Sell	1,000	$109.49	$109,490.00	10,099
8/30/2016	Kimberly S Taylor	Insider	Sell	2,300	$107.16	$246,468.00	101,489
8/15/2016	Phupinder Gill	CEO	Sell	20,080	$104.54	$2,099,163.20	154,141
8/11/2016	Ronald A Pankau	Director	Sell	400	$103.32	$41,328.00	4,382
8/4/2016	Julie Holzrichter	COO	Sell	2,425	$103.03	$249,847.75	32,620
8/2/2016	Derek Sammann	Insider	Sell	3,550	$103.20	$366,360.00	30,896
8/1/2016	Kimberly S Taylor	Insider	Sell	2,300	$102.58	$235,934.00	103,789
7/15/2016	James E Oliff	Director	Sell	1,000	$102.30	$102,300.00
6/30/2016	Kimberly S Taylor	Insider	Sell	2,300	$96.55	$222,065.00	106,089
6/28/2016	Phupinder Gill	CEO	Sell	31,120	$93.14	$2,898,516.80	165,181
6/13/2016	Kevin Kometer	Insider	Sell	3,825	$95.50	$365,287.50	46,351
6/6/2016	John W Pietrowicz	CFO	Sell	3,900	$96.72	$377,208.00	46,393
6/6/2016	Kathleen M Cronin	Insider	Sell	6,200	$96.84	$600,408.00	30,774
6/3/2016	Kimberly S Taylor	Insider	Sell	7,400	$96.38	$713,212.00	115,789
5/31/2016	Kimberly S Taylor	Insider	Sell	2,300	$98.62	$226,826.00	108,389
4/28/2016	Kimberly S Taylor	Insider	Sell	2,300	$92.68	$213,164.00	110,689
3/30/2016	Kimberly S Taylor	Insider	Sell	2,300	$95.62	$219,926.00	112,989
3/11/2016	Kevin Kometer	Insider	Sell	500	$93.93	$46,965.00	38,305
3/9/2016	Terrence A Duffy	Chairman	Sell	15,340	$93.51	$1,434,443.40	92,244
3/4/2016	Hilda Harris Piell	Insider	Sell	252	$95.00	$23,940.00	22,618
3/1/2016	John W Pietrowicz	CFO	Sell	500	$91.68	$45,840.00	39,979
2/26/2016	Ronald A Pankau	Director	Sell	200	$93.50	$18,700.00	3,707
2/22/2016	Hilda Harris Piell	Insider	Sell	1,145	$94.00	$107,630.00	24,015
12/3/2015	Robert Zagotta	Insider	Sell	2,224	$95.71	$212,859.04	12,968
10/30/2015	James E Oliff	Director	Sell	1,000	$94.91	$94,910.00
6/12/2015	Kathleen M Cronin	Insider	Sell	6,500	$98.44	$639,860.00
6/3/2015	Kathleen M Cronin	Insider	Sell	2,000	$95.00	$190,000.00
6/2/2015	John W Pietrowicz	CFO	Sell	1,010	$93.59	$94,525.90
6/1/2015	Phupinder Gill	CEO	Sell	5,000	$94.02	$470,100.00
5/29/2015	Terrence A Duffy	Chairman	Sell	29,496	$93.87	$2,768,789.52
5/27/2015	Kevin Kometer	Insider	Sell	4,500	$94.02	$423,090.00
4/2/2015	John W Pietrowicz	CFO	Sell	1,000	$94.68	$94,680.00
3/20/2015	Phupinder Gill	CEO	Sell	30,000	$99.76	$2,992,800.00
3/16/2015	Jill A Harley	CAO	Sell	1,950	$100.00	$195,000.00
3/16/2015	Kimberly S Taylor	Insider	Sell	13,000	$100.00	$1,300,000.00
2/25/2015	Derek Sammann	Insider	Sell	4,770	$96.54	$460,495.80
2/11/2015	Terrence A Duffy	Chairman	Sell	30,875	$94.55	$2,919,231.25
2/6/2015	Hilda Harris Piell	Insider	Sell	1,600	$94.00	$150,400.00
12/8/2014	Hilda Harris Piell	Insider	Sell	5,825	$89.00	$518,425.00
11/3/2014	Kathleen M Cronin	Insider	Sell	1,920	$84.52	$162,278.40
11/3/2014	Terrence A Duffy	Chairman	Sell	14,580	$84.55	$1,232,739.00
10/1/2014	Jill A Harley	CAO	Sell	1,200	$79.99	$95,988.00
9/15/2014	Hilda Harris Piell	Insider	Sell	5,497	$79.41	$436,516.77
9/15/2014	Jill A Harley	CAO	Sell	2,820	$80.00	$225,600.00
9/2/2014	Bryan T Durkin	COO	Sell	25,625	$76.75	$1,966,718.75
7/23/2014	Hilda Harris Piell	Insider	Sell	2,282	$75.00	$171,150.00
7/23/2014	Jill A Harley	CAO	Sell	2,710	$75.00	$203,250.00
6/2/2014	Phupinder Gill	CEO	Sell	49,000	$71.66	$3,511,340.00
5/22/2014	Hilda Harris Piell	Insider	Sell	4,730	$70.00	$331,100.00	21,135
5/21/2014	C Odom II	Director	Sell	2,000	$69.62	$139,240.00	3
3/6/2014	Phupinder Gill	CEO	Sell	25,000	$77.00	$1,925,000.00	114,365
2/19/2014	C Odom II	Director	Sell	2,000	$75.91	$151,820.00	2,003
2/12/2014	C Odom II	Director	Sell	2,000	$76.04	$152,080.00	4,003
2/6/2014	C Odom II	Director	Sell	2,000	$73.59	$147,180.00	6,003
11/19/2013	C Odom II	Director	Sell	1,532	$80.03	$122,605.96	8,503
9/16/2013	James Pieper	CAO	Sell	3,785	$72.47	$274,298.95	4,793
9/4/2013	Linda Dallas Rich	Insider	Sell	1,737	$72.50	$125,932.50
8/29/2013	James Pieper	CAO	Sell	8,584	$70.33	$603,712.72	4,762
8/15/2013	Derek Sammann	Insider	Sell	10,530	$74.78	$787,433.40	18,100
8/14/2013	Derek Sammann	Insider	Sell	2,500	$74.11	$185,275.00	18,100
6/17/2013	Hilda Harris Piell	Insider	Sell	5,315	$75.00	$398,625.00
6/12/2013	Kathleen M Cronin	Insider	Sell	3,135	$72.66	$227,789.10
5/30/2013	Hilda Harris Piell	Insider	Sell	2,100	$70.00	$147,000.00
5/28/2013	James E Parisi	CFO	Sell	37,000	$65.72	$2,431,640.00
5/20/2013	Hilda Harris Piell	Insider	Sell	2,600	$64.78	$168,428.00
3/12/2013	C C Odom II	Director	Sell	2,243	$62.54	$140,277.22
3/12/2013	Ken Vroman	Insider	Sell	1,492	$62.69	$93,533.48
3/11/2013	Kevin Kometer	Insider	Sell	10,443	$62.42	$651,852.06
1/17/2013	Linda Dallas Rich	Insider	Sell	4,350	$55.00	$239,250.00

(Data available from 1/1/2013 forward)

CME Group (NASDAQ CME) News Headlines

Source:

Date	Headline
	CME Group (CME) to Release Quarterly Earnings on Thursday www.americanbankingnews.com - April 19 at 1:56 AM
	Norges Bank - Form 8.3 - NEX Group PLC www.finanznachrichten.de - April 17 at 9:28 AM
	CME Group (CME) Reports Record International ADV of 4.7 Million Contracts in Q1 www.streetinsider.com - April 16 at 9:00 AM
	CME Group Reaches Record International Average Daily Volume of 4.7 Million ... www.prnewswire.com - April 16 at 9:00 AM
	BRIEF-CME Group Says Q1 Average Daily Volume Of 4.7 Mln Contracts, Up 38 pct From Q1 2017 www.reuters.com - April 16 at 9:00 AM
	CME Group Reaches Record International Average Daily Volume of 4.7 Million Contracts in Q1 2018, Up 38 Percent from Q1 2017 finance.yahoo.com - April 16 at 9:00 AM
	[$$] Did Chicago Exchanges Muscle a Rival Out of Town? A Jury May Soon Decide finance.yahoo.com - April 15 at 10:11 AM
	$1.08 Billion in Sales Expected for CME Group (CME) This Quarter www.americanbankingnews.com - April 15 at 6:59 AM
	CME Group (CME) Given a $135.00 Price Target at Royal Bank of Canada www.americanbankingnews.com - April 14 at 11:49 AM
	CME Group (CME) Upgraded to "Hold" by BidaskClub www.americanbankingnews.com - April 13 at 4:55 PM
	Why CME Group Inc (NASDAQ:CME) Could Be A Buy finance.yahoo.com - April 13 at 4:47 PM
	Actions taken on Russian firms by market institutions after new US sanctions www.reuters.com - April 13 at 9:23 AM
	FORM 8.5 (EPT/NON-RI) - CME GROUP PLC www.businesswire.com - April 13 at 9:23 AM
	CME Group to Post Q2 2018 Earnings of $1.64 Per Share, Jefferies Group Forecasts (CME) www.americanbankingnews.com - April 13 at 8:51 AM
	Zacks: Brokerages Anticipate CME Group (CME) Will Post Earnings of $1.85 Per Share www.americanbankingnews.com - April 13 at 1:25 AM
	METALS-Aluminium extends rally after LME, CME suspend Rusal metal www.cnbc.com - April 12 at 9:54 AM
	CME Sustaining Growth Momentum Across Asset Classes In Q1 www.forbes.com - April 12 at 9:54 AM
	Brokers Issue Forecasts for CME Group's Q1 2018 Earnings (CME) www.americanbankingnews.com - April 12 at 7:13 AM
	CME revokes approved status for Rusal's aluminium www.reuters.com - April 11 at 4:47 PM
	Form 8.5 (EPT/NON-RI) - CME Group Plc - Amendment www.businesswire.com - April 11 at 4:47 PM
	Form 8 (DD) - CME Group Plc www.businesswire.com - April 11 at 4:47 PM
	6 Reasons Why You Must Add CME Group (CME) to Your Portfolio finance.yahoo.com - April 11 at 4:47 PM
	Russia says will give sanction-hit Rusal short-term liquidity finance.yahoo.com - April 11 at 4:47 PM
	CME revokes approved status for Rusal's aluminum www.reuters.com - April 11 at 9:41 AM
	Aluminium prices hit 3-month high after LME, CME restrict Rusal metal www.ft.com - April 11 at 9:41 AM
	CME Group (CME) CFO John W. Pietrowicz Sells 2,500 Shares www.americanbankingnews.com - April 10 at 7:11 PM
	CME Group (CME) Now Covered by Sanford C. Bernstein www.americanbankingnews.com - April 9 at 5:16 PM
	[$$] Livestock and Grain Traders Navigate Murkier Market finance.yahoo.com - April 8 at 10:25 AM
	CME Group (CME) PT Raised to $149.00 at Barclays www.americanbankingnews.com - April 7 at 4:29 PM
	BidaskClub Lowers CME Group (CME) to Buy www.americanbankingnews.com - April 6 at 7:00 PM
	CME Group (CME) Given New $197.00 Price Target at Deutsche Bank www.americanbankingnews.com - April 6 at 2:28 PM
	CME Group (CME) Lifted to Buy at Zacks Investment Research www.americanbankingnews.com - April 6 at 10:59 AM
	Equities Analysts Offer Predictions for CME Group's FY2020 Earnings (CME) www.americanbankingnews.com - April 6 at 8:23 AM
	CME Group (CME) Downgraded by BidaskClub to Hold www.americanbankingnews.com - April 5 at 6:52 PM
	CME Group's (CME) Q1 Volumes Mark Highest Quarterly ADV finance.yahoo.com - April 5 at 4:42 PM
	CME Group Inc (CME) Receives Average Recommendation of "Buy" from Brokerages www.americanbankingnews.com - April 5 at 1:21 PM
	CME Group's (CME) Q1 Volumes Mark Highest Quarterly ADV www.zacks.com - April 5 at 11:12 AM
	FY2018 Earnings Forecast for CME Group Inc (CME) Issued By Jefferies Group www.americanbankingnews.com - April 5 at 9:03 AM
	BRIEF-CME Group And GCSA Capital Collaborate To Deliver PTF Collateral Program www.reuters.com - April 4 at 3:33 PM
	[$$] Rise in Russian grain exports spurs trading in new wheat contract finance.yahoo.com - April 4 at 9:14 AM
	CME Group (CME) Upgraded to "Buy" by ValuEngine www.americanbankingnews.com - April 3 at 5:52 PM
	CME Group (CME) Reports Highest-Ever Quarterly ADV of 22.2 Million Contracts www.streetinsider.com - April 3 at 9:22 AM
	Busy Q1 action for CME Group seekingalpha.com - April 3 at 9:22 AM
	CME Group Reaches Highest-Ever Quarterly Average Daily Volume of 22.2 Million Contracts for First-Quarter 2018 finance.yahoo.com - April 3 at 9:22 AM
	China tariff hike on U.S. pork sinks CME hogs to 16-month low www.cnbc.com - April 2 at 4:46 PM
	CME will not sell assets after NEX Group acquisition seekingalpha.com - April 2 at 4:46 PM
	[$$] CME rules out asset sales after Nex deal finance.yahoo.com - April 2 at 9:36 AM
	CME Group (CME) Upgraded at Zacks Investment Research www.americanbankingnews.com - March 31 at 1:12 PM
	CME Group (CME) & Its Rivals Head-To-Head Review www.americanbankingnews.com - March 30 at 3:12 PM
	CME Group (CME) Upgraded to "Buy" at BidaskClub www.americanbankingnews.com - March 30 at 9:27 AM

CME Group (NASDAQ:CME) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

CME Group (NASDAQ:CME) Income Statement, Balance Sheet and Cash Flow Statement

CME Group (NASDAQ CME) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff